Michael Casamento
Executive Vice President & Chief Financial Officer at Amcor
Thanks, Ron, and hi, everyone. Beginning with the Flexibles segment on Slide 7, fiscal '23 reported sales were in line with last year, which included recovery of higher raw material costs of approximately $515 million, accounting for 5% sales growth. Excluding the raw material impact and negative currency movements, sales grew 1% for the year, driven by price/mix benefits of 4%, reflecting our ability to continue to price to recover inflation across all Flexibles business groups. This was partly offset by 3% lower volumes. And while volumes in all regions were impacted by slower demand and destocking, particularly in the second half of the year, our strategic focus on higher value priority categories continue to drive solid sales growth for the year. Volumes in the pharmaceutical and pet care categories were especially strong, helping to limit the impact of broad-based lower volumes in other categories.
As Ron mentioned, throughout the year, the business did a good job aligning operating costs with challenging market conditions, while pricing to recover inflation. This focus resulted in a 1% increase in adjusted EBIT for the year on a comparable constant currency basis. Margins remained strong at 12.8%, despite 100 basis-point dilution related to increased sales dollars from passing through higher raw material costs and general inflation.
In terms of the fourth quarter, net sales on a comparable constant currency basis were down 5% with positive price/mix of 2%, more than offset by a 7% decline in volume. This represents an accelerated volume decline compared with the March quarter, and with consistent trend across most regions. The greatest sequential declines continued to be seen in the North America and European markets, where overall June quarter volumes were lower by high single-digits, consistent with softer retail scanner data and with categories such as premium coffee, protein and healthcare also being incrementally impacted by customer destocking.
Adjusted EBIT for the quarter of $387 million, was 7% lower than the prior year on a comparable constant currency basis, reflecting the impact of lower volumes, unfavorable mix and ongoing inflation, partly offset by benefits from continued pricing and cost actions.
Turning to rigid packaging on Slide 8. Fiscal '23 reported net sales were 4% higher than the same period last year, including approximately $260 million or 8% of sales related to the pass through of higher raw material costs. Organic sales declined 3%, reflecting 4% lower volumes, partly offset by price/mix benefit of 1%. In North America, overall beverage volumes for the year were down 6%, hot fill volumes were in line with the prior year, as new business wins in key categories offset unfavorable consumer demand and customer destocking.
In specialty containers, volumes were lower than last year, with growth in the healthcare, dairy, and nutrition categories offset by weaker volumes in food, home, and personal care. And in Latin America, volumes were down low single digits versus last year, which reflects challenging macroeconomic conditions across the region. Fiscal '23 adjusted EBIT was down 7%, as strong earnings growth in the first half was more than offset by challenging market conditions that has accelerated through the second half of the year. Adjusted EBIT margin of 7.5% includes an adverse impact of approximately 80 basis points from the increased sales dollars to related -- related to passing through higher raw material costs and general inflation.
Looking at the June quarter, comparable constant currency net sales were down 4%. Price/mix benefits of 2% were more than offset by a 6% volume decline as lower consumer demand and customer destocking continued to impact the business, particularly in North America. On a comparable constant currency basis, adjusted EBIT for the quarter of $73 million was down $22 million against the strong comparative period.
As Ron mentioned earlier, the June quarter is typically the seasonally strongest of the year. And together with volatility in customer order patterns, this limits the ability to fully flex costs. In an environment where production volumes are weaker, fixed cost absorption is also significantly lower. And the combination of these factors amplifies the impact on earnings.
The team continued to manage the cost under their control, while with -- additional headcount reduction is in more plant shutdown days. And we continue to focus on cost actions as we manage through the cycle of softer demand and destocking.
Looking ahead to the September quarter, we do not anticipate market challenges to materially improve, which will have an unfavorable impact on earnings compared with the same quarter last year.
Moving to cash and the balance sheet on Slide 9. Our financial profile and investment grade balance sheet remained strong. Leverage at 3 times on a trailing 12-month EBITDA basis is modestly up from last year, but it's in line with our expectations given the softer demand and broad-based destocking through the supply chain.
Adjusted free cash flow of $848 million was in line with our updated outlook though below last year. This reduction mostly reflects lower accounts payable balances as we moderated our purchasing activities partly to reduce inventories, but also in response to the soft demand environment. This is a timing impact, which we expect will abate as we progress through fiscal '24. And whilst we have made good progress bringing down our inventory balances with the reduction of more than $400 million from the peak levels in November '22, we will continue to focus on reducing overall working capital to support increasing cash flow.
Turning now to the outlook for fiscal 2024 on Slide 10. For the '24 fiscal year, we expect adjusted EPS of approximately $0.67 to $0.71 per share. This includes expectations that organic growth from the underlying business will be in the plus or minus low single-digit range, as volumes are expected to remain weak, particularly in the first half.
Share repurchases will result in a benefit of approximately 2%, and currency translation is expected to add a further benefit of 2%, assuming current exchange rates prevail for the balance of the fiscal year. This is expected to be offset by negative impact of approximately 3%, related to the sale of our three plants in Russia in December 2022, and a negative impact of approximately 6% from higher interest and tax expense.
As the U.S. dollar and euro interest rates have continued to rise, we expect interest expense for fiscal '24 to be in the range of $320 million to $340 million. In terms of cash flow, we expect to generate significant adjusted free cash flow in the range of $850 million to $950 million in fiscal '24, which represents growth of up to a $100 million over fiscal 2023. We have plan to repurchase at least $70 million of Amcor shares in '24, and we have been active on the acquisition front and we'll continue to pursue M&A opportunities. And as always, we will evaluate our uses of cash as we progress through the year.
Slide 11 shows that Amcor has a long history of delivering solid and consistent earnings growth and the phasing of the earnings across the year has also been relatively consistent year-to-year. For fiscal '24, it's important to call out that phasing of comparable earnings growth is not expected to align with historical trend. We do not expect the challenging market dynamics we've seen in the last two quarters to meaningfully improve in the near-term. And in the first half, we assume mid to high single-digit volume declines.
Given this demand outlook and the unfavorable impact related to higher interest expense, which is expected to moderate in the second half, we anticipate adjusted EPS in the first half of fiscal '24 to be down in the high single-digit to low double-digit range on a comparable constant currency basis when compared to the prior year. While it's more difficult to predict consumer demand, we do expect customer inventories will largely normalize by the time we enter the second half of the fiscal year.
Additionally, we have a number of tailwinds in the second half, all of which are within our control, including the benefit of approximately $35 million from structural cost saving initiatives building through the year, increased earnings leverage resulting from ongoing benefits from price and cost actions, reduced interest headwind and favorable prior year volume comparatives. The combination of these known factors supports our expectation that adjusted EPS rose mid single-digits in the second half of fiscal '24 on a comparable constant currency basis. It also gives us confidence in resuming our long-term trend of high single-digit earnings growth shortly thereafter. It's also important to highlight here that we do not need to see a significant change in the demand environment, a return to solid earning growth in the second half and beyond.
So in summary, we believe the current industry and Amcor specific challenges will primarily be limited to the 2023 calendar year. We remain laser-focused on doing all we can to mitigate the impacts of these challenging conditions, while continuing to execute our long-term shareholder value-creation strategy. And we expect to return to our historic high single-digit organic growth effectively as we progress through calendar year 2024.
With that, I will turn the call back to Ron, to provide some longer-term comments.